Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions

: Medicinal Product - Herceptin (trastazumab) 150 mg for Intravenous Use - XML Representation

Raw xml | Download



<MedicinalProductDefinition xmlns="http://hl7.org/fhir">
  <id value="medprodherceptin150"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="medprodherceptin150"> </a><a name="hcmedprodherceptin150"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceMedicinalProductDefinition &quot;medprodherceptin150&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://iyaku.info/medicine</code>/4291447D2024</p><p><b>type</b>: Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Herceptin (trastazumab) 150 mg</p><p><b>type</b>: Full name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Herceptin</p><p><b>type</b>: Invented name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: trastazumab</p><p><b>type</b>: Scientific name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 150 mg</p><p><b>type</b>: Strength part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Intravenous infusion</p><p><b>type</b>: Pharmaceutical dose form part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#100000075213)</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td>Japan <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#JP)</span></td><td>Japan <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#JP)</span></td><td>Japanese (Region=Japan) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#ja-JP)</span></td></tr></table></blockquote></div>
  </text>
  <identifier>
    <system value="http://iyaku.info/medicine"/>
    <value value="4291447D2024"/>
  </identifier>
  <type>
    <coding>
      <system value="http://hl7.org/fhir/medicinal-product-type"/>
      <code value="MedicinalProduct"/>
      <display value="Medicinal Product"/>
    </coding>
  </type>
  <domain>
    <coding>
      <system value="http://hl7.org/fhir/medicinal-product-domain"/>
      <code value="Human"/>
      <display value="Human use"/>
    </coding>
  </domain>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
      <display value="active"/>
    </coding>
  </status>
  <legalStatusOfSupply>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi"/>
      <code value="100000072084"/>
      <display value="Medicinal product subject to medical prescription"/>
    </coding>
  </legalStatusOfSupply>
  <name>
    <productName value="Herceptin (trastazumab) 150 mg"/>
    <type>
      <coding>
        <system value="https://spor.ema.europa.eu/lists/220000000000"/>
        <code value="220000000001"/>
      </coding>
      <text value="Full name"/>
    </type>
    <part>
      <part value="Herceptin"/>
      <type>
        <coding>
          <system value="https://spor.ema.europa.eu/lists/220000000000"/>
          <code value="220000000002"/>
        </coding>
        <text value="Invented name part"/>
      </type>
    </part>
    <part>
      <part value="trastazumab"/>
      <type>
        <coding>
          <system value="https://spor.ema.europa.eu/lists/220000000000"/>
          <code value="220000000003"/>
        </coding>
        <text value="Scientific name part"/>
      </type>
    </part>
    <part>
      <part value="150 mg"/>
      <type>
        <coding>
          <system value="https://spor.ema.europa.eu/lists/220000000000"/>
          <code value="220000000004"/>
        </coding>
        <text value="Strength part"/>
      </type>
    </part>
    <part>
      <part value="Intravenous infusion"/>
      <type>
        <coding>
          <system value="https://spor.ema.europa.eu/lists/220000000000"/>
          <code value="100000075213"/>
        </coding>
        <text value="Pharmaceutical dose form part"/>
      </type>
    </part>
    <usage>
      <country>
        <coding>
          <system value="urn:iso:std:iso:3166"/>
          <code value="JP"/>
        </coding>
      </country>
      <jurisdiction>
        <coding>
          <system value="urn:iso:std:iso:3166"/>
          <code value="JP"/>
        </coding>
      </jurisdiction>
      <language>
        <coding>
          <system value="urn:ietf:bcp:47"/>
          <code value="ja-JP"/>
        </coding>
      </language>
    </usage>
  </name>
</MedicinalProductDefinition>